Papagiannis, D, Laios, T, Tryposkiadis, K, Kouriotis, K, Roussis, X, Basdekis, G, Boudouris, P, Cholevas, C, Karakitsios, S, Kakavas, P, Kiriakidis, T, Kouloumentas, P, Kouvidis, G, Manoudis, G, Nikolaou, P, Theos, C, Piskopakis, A.-N, Rallis, I, Ristanis, S, Toliopoulos, A, Zisis, G, Theodorakis, Y, Gourgoulianis, K. I., Rachiotis, G & Rachiotis, G. (2022). COVID-19 Infection among elite football players: A nationwide prospective cohort study. Vaccines, 10 (5), 634. Zugriff am 06.05.2022 unter https://doi.org/10.3390/vaccines10050634
APA-Zitierstil (7. Ausg.)Papagiannis, D., Laios, T., Tryposkiadis, K., Kouriotis, K., Roussis, X., Basdekis, G., . . . Rachiotis, G. (2022). COVID-19 Infection among elite football players: A nationwide prospective cohort study. Vaccines, 10(5), 634.
Chicago-Zitierstil (17. Ausg.)Papagiannis, D., et al. "COVID-19 Infection Among Elite Football Players: A Nationwide Prospective Cohort Study." Vaccines 10, no. 5 (2022): 634.
MLA-Zitierstil (9. Ausg.)Papagiannis, D., et al. "COVID-19 Infection Among Elite Football Players: A Nationwide Prospective Cohort Study." Vaccines, vol. 10, no. 5, 2022, p. 634.